【答案】应助回帖

» 猜你喜欢

是否属于脾肾阳虚证已经有0人回复
是不是现在考博都是推荐制？或者是已经内定了？还有通过考试招博士的学校吗？已经有39人回复
药物学论文润色/翻译怎么收费? 已经有174人回复
农产品中农药监测的免疫传感器的疑问已经有0人回复
纳米传感器监测农药残留的疑惑已经有0人回复
各位大佬，H口面上什么时候会评？？？已经有30人回复
谁有人卫版《毒理学基础》第七版书籍已经有0人回复
26有没有老师想收做定量药理的学生啊已经有2人回复
26考博申请学or专已经有15人回复
2026年山东大学海洋学院生物与医药博士招生-李霞课题组已经有0人回复
博士研究生招生已经有0人回复

» 本主题相关价值贴推荐，对您同样有帮助:

【求助】谁能帮忙购买“[施太可]盐酸索他洛尔片，中美上海施贵宝制药有限公司” 已经有15人回复

1楼2013-10-18 12:24:41

e_liang369

金虫 (正式写手)

应助: 340 (大学生)
金币: 2491.9
红花: 12
帖子: 819
在线: 737.3小时
虫号: 2456033
注册: 2013-05-09
性别: GG
专业: 药物分析

【答案】应助回帖

感谢参与，应助指数 +1

直接到drugfuture上去查
http://www.drugfuture.com/standard/

悲催的研发！

2楼2013-10-18 12:28:32

hfsr

银虫 (初入文坛)

应助: 0 (幼儿园)
金币: 271
帖子: 20
在线: 23.3小时
虫号: 2527899
注册: 2013-07-01

引用回帖:

2楼: Originally posted by e_liang369 at 2013-10-18 12:28:32
直接到drugfuture上去查
http://www.drugfuture.com/standard/

那上面没有USP36版啊

3楼2013-10-19 20:33:53

qiuqinglei5020

金虫 (小有名气)

硫酸大师

应助: 2 (幼儿园)
金币: 131
散金: 27
红花: 6
帖子: 138
在线: 71.3小时
虫号: 1083266
注册: 2010-08-27
性别: GG
专业: 药物分析

这个一定没有USP36，你也别找了！

4楼2013-10-20 12:24:43

06药学

木虫 (著名写手)

DRDEPI: 1
应助: 24 (小学生)
金币: 6679.8
散金: 16
红花: 3
帖子: 1041
在线: 543.6小时
虫号: 525221
注册: 2008-03-14
性别: GG
专业: 药物分析

【答案】应助回帖

★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与，应助指数 +1
hfsr(zhychen2008代发): 金币+10, 多谢回帖交流 2013-10-20 23:08:46

Memantine Hydrochloride Tablets
DEFINITION

Memantine Hydrochloride Tablets contain an amount of memantine hydrochloride equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of memantine hydrochloride (C12H21N ·HCl).
IDENTIFICATION
•  A. Infrared Absorption  197K
Analytical range: 4000 to 400 cm –1
Standard: 6.7 mg/mL of USP Memantine Hydrochloride RS in dichloromethane. Shake for 10 min, and pass through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide.
Sample: 6.7 mg/mL of Memantine Hydrochloride in dichloromethane from NLT 20 crushed Tablets. Shake for 10 min, and centrifuge for 10 min. Pass the supernatant through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide.
Acceptance criteria: Fingerprint region of the Standard and Sample spectrum exhibit maxima at the same wave numbers.
•  B. The retention time of the memantine peak in the Sample solution corresponds to that of the memantine peak in the Standard solution, as obtained in the Assay.
ASSAY
•  Procedure
Solution A: 200 mg/mL of sodium hydroxide in water
Internal standard solution: 25 µg/mL of USP Amantadine Hydrochloride RS in water
Standard stock solution: 25 µg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add methanol to fill 40% of the final flask volume, and sonicate. Dilute with water to volume.
Standard solution: Pipet 4.0 mL each of Internal standard solution and Standard stock solution into a test tube. Add 2 mL of Solution A, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 3 min. Allow the two layers to separate. Inject the toluene layer.
Sample stock solution: Nominally 20 µg/mL of memantine hydrochloride prepared as follows. Transfer a suitable number of Tablets to a volumetric flask to obtain a 0.1 mg/mL memantine hydrochloride solution. Add methanol to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Add water to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Dilute with water to volume, and centrifuge a portion for 10 min. Pipet a suitable volume of the clear centrifugate into a volumetric flask, and dilute with water to volume.
Sample solution: Pipet 5.0 mL of the Sample stock solution, 4.0 mL of Internal standard solution, and 2 mL of Solution A into a test tube, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 5 min. Allow the two layers to separate. Inject the toluene layer.
Blank: To 5.0 mL of 80 µL/mL of methanol in water add 2 mL Solution A, and mix on a vortex mixer for 1 min. Add 4.0 mL of tolune, and cyclomix on vortex for 5 min. Allow the two layers to separate. Inject the toluene layer.
Chromatographic system
(See Chromatography  621 , System Suitability.)
Mode: GC
Detector: Flame ionization
Column: 30-m × 0.32-mm; 0.25-µm packing G27
Temperatures
Injection port: 210
Detector: 300
Oven: See Table 1.
Table 1
Initial
Temperature
() Temperature
Ramp
(/min) Final
Temperature
() Hold Time at Final
Temperature
(min)
50 0 50 2
50 20 140 0
140 30 200 5
Carrier gas: Helium
Flow rate: 34.8 psi
Injection volume: 4 µL
Injection type: Split ratio, 1:10
System suitability
Sample: Standard solution
[ NOTE— The relative retention times for amantadine and memantine are 0.97 and 1.0, respectively. ]
Suitability requirements
Resolution: NLT 2.0 between amantadine and memantine
Tailing factor: NMT 2.5 for amantadine and NMT 2.0 for memantine
Relative standard deviation: NMT 2.0% for the ratio of the peak areas of amantadine and memantine
Analysis
Samples: Standard solution, Sample solution, and Blank

Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ·HCl) in the portion of Tablets taken:
Result = ( R U / R S ) × ( C S / C U ) × 100
R U = peak area ratio of memantine to amantadine from the Sample solution
R S = peak area ratio of memantine to amantadine from the Standard solution
C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (µg/mL)
C U = nominal concentration of memantine hydrochloride in the Sample solution (µg/mL)
Acceptance criteria: 90.0%–110.0%
PERFORMANCE TESTS
• Dissolution  711
Medium: 0.1 N hydrochloric acid with sodium chloride (2g/L of sodium chloride in water), adjusted with hydrochloric acid to a pH of 1.2; 900 mL
Apparatus 1: 100 rpm
Time: 30 min
Standard stock solution: (L/900) mg/mL of USP Memantine Hydrochloride RS in Medium, where L is the label claim in mg/Tablet
Internal standard solution: 28 µg/mL of USP Amantadine Hydrochloride RS in Medium
Standard solution
For Tablets labeled to contain 5 mg: Transfer 5 mL of the Standard stock solution to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
For Tablets labeled to contain 10mg: Transfer 5 mL of the Standard stock solution to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
Sample solution: Pass a portion of the solution under test through a suitable filter.
For Tablets labeled to contain 5 mg: Transfer 5 mL of the filtrate to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
For Tablets labeled to contain 10 mg: Transfer 5 mL of the filtrate to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
Chromatographic system
(See Chromatography  621 , System Suitability.)
Mode: GC, splitless
Detector: Flame ionization
Column: 30-m × 0.32-mm; 0.25-µm packing G27
Flow rate: 34.8 psi
Temperatures
Injection port: 210
Detector: 300
Oven: See Table 2.
Table 2
Initial
Temperature
() Temperature
Ramp
(/min) Final
Temperature
() Hold Time at Final
Temperature
(min)
50 0 50 2
50 20 140 0
140 30 200 5
Carrier gas: Helium
Injection volume: 4 µL
System suitability
Sample: Standard solution
Suitability requirements
Resolution: NLT 2.0 between amantadine and memantine
Tailing factor: NMT 2.0 each for amantadine and memantine
Relative standard deviation: NMT 2.0% for both the amantadine and memantine peaks
Analysis
Samples: Standard solution and Sample solution

Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ·HCl) dissolved:
Result = ( R u / R s ) × ( C s /L) × V × 100
R U = peak area ratio of memantine to amantadine from the Sample solution
R S = peak area ratio of memantine to amantadine from the Standard solution
C S = concentration of USP Memantine Hydrochloride RS from the Standard solution (µg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Tolerances: NLT 80% (Q) of the labeled amount of memantine hydrochloride (C12H21N ·HCl) is dissolved.
• Uniformity of Dosage Units  905 : Meet the requirements
IMPURITIES
•  Limit of Memantine–Lactose Adduct
[ NOTE— Perform this test if lactose is present in the formulation. ]
Solution A: 40 mg/mL of sodium hydroxide in water
Buffer: Dissolve 3.3 g of monobasic potassium phosphate and 2.3 g of sodium 1-octane sulfonate in 1 L of water. Adjust with Solution A to a pH of 6.1.
Mobile phase: Acetonitrile, methanol, and Buffer (26:4:70)
Standard solution: 0.2 mg/mL of USP Memantine Hydrochloride RS in Mobile phase
Sample solution: Nominally 10 mg/mL of memantine hydrochloride from NLT 25 crushed Tablets, prepared as follows. Transfer an amount of powder equivalent to 100 mg of memantine hydrochloride to a 20-mL volumetric flask. Add 10 mL of Mobile phase, and sonicate for 30 min. Centrifuge, and pass a portion of the centrifugate through a suitable filter of 0.45-µm pore size.
Chromatographic system
(See Chromatography  621 , System Suitability.)
Mode: LC
Detector: Refractive index
Column: 4.6-mm × 15-cm; 5-µm packing L1
Temperatures
Column: 40
Detector: 35
Flow rate: 1.3 mL/min
Injection volume: 50 µL
Run time: 1.3 times the retention time of the memantine peak
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 3.5
Relative standard deviation: NMT 10.0%
Analysis
Samples: Standard solution and Sample solution

Calculate the percentage of the memantine–lactose adduct in the portion of Tablets taken:
Result = ( r U / r S ) × ( C S / C U ) × (1/F) × 100
r U = peak response of the memantine–lactose adduct from the Sample solution
r S = peak response of memantine from the Standard solution
C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL)
C U = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL)
F = relative response factor of the memantine–lactose adduct (see Table 3)
Acceptance criteria: See Table 3.
Disregard all peaks other than the memantine–lactose adduct peak.
Table 3
Name Relative
Retention
Time Relative
Response
Factor Acceptance
Criteria,
NMT (%)
Memantine–lactose adduct 0.41 0.53 0.5
Memantine 1.0 1.0    —
•  Organic Impurities
Solution A: 1 N sodium hydroxide
Standard stock solution A: 0.5 mg/mL each of USP Memantine Related Compound A RS, USP Memantine Related Compound B RS, USP Memantine Related Compound C RS, USP Memantine Related Compound D RS, and USP Memantine Related Compound E RS in n-hexane
Standard stock solution B: 12.5 mg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 15% of the final flask volume and n-hexane to fill 10% of the final flask volume. Mix for 10 min.
System suitability solution: Pipet 4.0 mL of the n-hexane layer from Standard stock solution B into a 10-mL volumetric flask. Add 0.5 mL of Standard stock solution A, and dilute with n-hexane to volume.
Standard stock solution: 1.3 mg/mL of USP Memantine Hydrochloride RS in n-hexane prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 30% of the final flask volume, and mix for 5 min. Add n-hexane to fill 40% of the final flask volume, and shake for 10 min. Transfer the contents of the flask into a separator. Allow the layers to separate, and filter a portion of the top n-hexane layer through anhydrous sodium sulfate. Use the clear solution.
Standard solution: Pipet 2.0 mL of the clear solution from the Standard stock solution into a 100-mL volumetric flask, and dilute with n-hexane to volume.
Sample solution: Nominally 5 mg/mL of memantine hydrochloride in n-hexane from NLT 20 crushed Tablets, prepared as follows. Transfer a weighed amount of powder equivalent to 100 mg of memantine hydrochloride to a suitable volumetric flask. Add Solution A to fill 15% of the final flask volume. Shake to disperse the material, and shake for 5 min. Sonicate for 5 min with intermittent shaking. Add n-hexane to fill 20% of the final flask volume, and shake for 10 min. Transfer the contents into a separator. Allow the layers to separate, and filter a portion of the top hexane layer through anhydrous sodium sulfate. Use the clear solution.
Chromatographic system
(See Chromatography  621 , System Suitability.)
Mode: GC
Detector: Flame ionization
Column: 50-m × 0.32-mm; 0.52-µm packing G27
Temperatures
Injection port: 220
Detector: 300
Oven: See Table 4.
Table 4
Initial
Temperature
() Temperature
Ramp
(/min) Final
Temperature
() Hold Time at Final
Temperature
(min)
50 0 50 2
50 5 145 0
145 10 250 20
Carrier gas: Helium
Flow rate: 4.0 ± 0.2 mL/min
Injection volume: 3 µL
Injection type: Split ratio, 1:20
System suitability
Samples: System suitability solution and Standard solution
[ NOTE— See Table 5 for the relative retention times. ]
Suitability requirements
Resolution: NLT 2.0 between memantine and memantine related compound B, NLT 2.0 between memantine related compound B and memantine related compound C, System suitability solution
Tailing factor: NMT 2.0, Standard solution
Relative standard deviation: NMT 10.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution

Calculate the percentage of USP Memantine Related Compound E RS or any individual degradation product in the portion of Tablets taken:
Result = ( r U / r S ) × ( C S / C U ) × 100
r U = peak response of USP Memantine Related Compound E RS or any individual degradation product from the Sample solution
r S = peak response of memantine hydrochloride from the Standard solution
C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL)
C U = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: See Table 5.
Table 5
Name Relative
Retention
Time Acceptance
Criteria,
NMT (%)
Memantine related compound Aa 0.77    —
Memantine 1.0    —
Memantine related compound Ba 1.03    —
Memantine related compound Ca 1.1    —
Memantine related compound Da 1.2    —
Memantine related compound E 1.4 0.15
Any individual unspecified degradation product    — 0.20
Total impuritiesb    — 0.5
a Process impurities controlled in the drug substance and are included for identification only. Not reported for the drug product and not included in the total impurities
b Excludes memantine–lactose adduct monitored in the test for Limit of Memantine–Lactose Adduct.
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in tight containers. Store at controlled room temperature.
• USP Reference Standards  11
USP Amantadine Hydrochloride RS
USP Memantine Hydrochloride RS
USP Memantine Related Compound A RS
1,3-Dimethyladamantane.
C12H20    164.29
USP Memantine Related Compound B RS
3,5-Dimethyladamantane-1-ol.
C12H20O    180.29
USP Memantine Related Compound C RS
1-Chloro-3,5-dimethyladamantane.
C12H19Cl    198.73
USP Memantine Related Compound D RS
1-Bromo-3,5-dimethyladamantane.
C12H19Br    243.18
USP Memantine Related Compound E RS
N-3,5-Dimethyladamantan-1-yl formamide.
C13H21NO    207.31

赞一下(5人)

» 本帖已获得的红花（最新10朵）

zhangpeino

学药为民

5楼2013-10-20 23:02:07

hfsr

银虫 (初入文坛)

应助: 0 (幼儿园)
金币: 271
帖子: 20
在线: 23.3小时
虫号: 2527899
注册: 2013-07-01

谢谢，

[ 发自手机版 http://muchong.com/3g ]

6楼2013-10-28 21:25:07

品味幸福

铜虫 (小有名气)

应助: 1 (幼儿园)
金币: 96.1
红花: 1
帖子: 57
在线: 46.2小时
虫号: 1251790
注册: 2011-04-01
专业: 药剂学

引用回帖:

5楼: Originally posted by 06药学 at 2013-10-20 23:02:07
Memantine Hydrochloride Tablets
DEFINITION

Memantine Hydrochloride Tablets contain an amount of memantine hydrochloride equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of memantine h ...

老师这个是什么标准？我咋没查到呢？

7楼2014-01-06 17:07:49